Eliquis demonstrated superiority in the primary safety endpoint of major

Eliquis demonstrated superiority in the primary safety endpoint of major … For patients receiving ELIQUIS doses greater than 2.5 mg twice daily, the dose of ELIQUIS should be decreased by 50% when it is coadministered with drugs that are strong … Continue reading

Posted in Pet Care Media | Tagged , , , , , , | Leave a comment